首页> 外文会议>International Conference on Medical Imaging Physics and Engineering >Constructing Novel Prognostic Biomarkers of Advanced Nasopharyngeal Carcinoma from Multiparametric MRI Radiomics Using Ensemble-Model Based Iterative Feature Selection
【24h】

Constructing Novel Prognostic Biomarkers of Advanced Nasopharyngeal Carcinoma from Multiparametric MRI Radiomics Using Ensemble-Model Based Iterative Feature Selection

机译:基于基于组合模型的迭代特征选择构建多射出鼻咽癌的新型鼻咽癌的新预后生物标志物

获取原文

摘要

Although different treatment strategies have been developed for nasopharyngeal carcinoma (NPC), recurrence and distant metastasis remain major challenges to advanced NPC. This study aims to identify pre-treatment radiomics models to predict progression-free survival (PFS) using pre-treatment T2weighted short tau inversion recovery (STIR) magnetic resonance (MR) images and contrast-enhanced T1-weighted MR images (CET1-W) separately. To address the problem of imbalanced and small dataset in model training, we developed a novel method named as ensemble-model based iterative feature selection for determine the predictive feature sets. Least absolute shrinkage and selection operator (LASSO) was used in both feature selection and model construction. Model ensemble was constructed from the subset of patients during the process of feature selection and model construction. In model construction, selected models built from predictive feature sets were then internally validated using 1000-bootstrapping for whole-patient cohort. Corrected AUC of Joint CET1-w and T2-w model was the highest and corrected AUC of T2-w modes was the lowest. Rad-scores were calculated as a linear combination of selected features for each patient, and were evaluated by stratified Kaplan-Meier analysis and Cox proportional hazard regression. Significant differences $(mathrm{p}lt 0.001)$ were observed between survival curves of high-risk and low-risk patients stratified by Rad-scores. Our results demonstrated the capability of the ensemble-model based iterative feature selection method for imbalanced and small dataset when building MRI-based biomarkers to stratify patients into high risk and low risk.
机译:虽然已经为鼻咽癌(NPC)开发了不同的治疗策略,但复发和远处转移仍然对先进的NPC进行重大挑战。本研究旨在鉴定使用预处理T2重量的短TAI恢复(搅拌)磁共振(MR)图像和对比度增强的T1加权MR图像(CET1-W ) 分别地。为了解决模型培训中的不平衡和小型数据集的问题,我们开发了一种名为基于集合模型的新颖方法,用于确定预测功能集。在特征选择和模型构造中使用最小绝对收缩和选择操作员(套索)。在特征选择和模型结构过程中,模型集合由患者的子集构成。在模型结构中,使用1000-Bootstrappte用于全患者队列,内部验证了从预测功能集内置的选定模型。矫正AUC的联合CET1-W和T2-W型号是T2-W模式的最高和校正的AUC是最低的。将Rad-S分数作为每位患者的所选特征的线性组合计算,并通过分层的Kaplan-Meier分析和Cox比例危害回归评估。通过Rad-Sicrors分层的高风险和低风险患者的存活曲线观察到显着差异$( mathrm {p} lt 0.001)。我们的结果表明,基于MRI的生物标志物将患者分析为高风险和低风险时,我们的结果表明了基于IMABLACED和小型数据集的基于模型的迭代特征选择方法。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号